Macquarie Downgrades Affymetrix (AFFX) to Neutral
Tweet Send to a FriendGet Alerts AFFX Hot Sheet
Price: $3.73 +1.63%
Rating Summary:
5 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
5 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade AFFX Now!
Macquarie downgrades Affymetrix (Nasdaq: AFFX) from Outperform to Neutral. PT cut from $12 to $4.65.
To see all the upgrades/downgrades on shares of AFFX, visit our Analyst Ratings page.
Affymetrix, Inc. (Affymetrix) develops, manufactures and sells products and services for genetic analysis to the life science research and clinical healthcare markets.
To see all the upgrades/downgrades on shares of AFFX, visit our Analyst Ratings page.
Affymetrix, Inc. (Affymetrix) develops, manufactures and sells products and services for genetic analysis to the life science research and clinical healthcare markets.
You May Also Be Interested In
- KeyBanc Downgrades Sanderson Farms (SAFM) to Hold
- Wells Fargo Cuts Comerica (CMA) and First Horizon National (FHN) to Underperform
- Barclays Downgrades American Capital Agency (AGNC) to Equalweight
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
